Immune cell boost may keep leukemia at bay after transplant
Disease control
Not yet recruiting
This study tests a stem cell transplant from a matched sibling donor combined with special immune cells (regulatory and conventional T cells) for people with high-risk acute myeloid leukemia (AML). The goal is to prevent the cancer from coming back. About 28 participants will rec…
Phase: PHASE2 • Sponsor: Antonio Pierini • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC